Stanley Fisher

Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®).

R. Hauser, L. Zeitlin, Stanley Fisher, 2020, Parkinsonism & related disorders.

Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome Dyskinesia

R. Hauser, L. Zeitlin, Stanley Fisher, 2020, Journal of Parkinson's disease.

Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary®): Results of a Nationwide Dose Conversion Survey

R. Hauser, Stanley Fisher, R. D'Souza, 2021, Parkinson's disease.

Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE‐PD Open‐Label Extension Study

A. Espay, H. Visser, Stanley Fisher, 2023, Movement disorders : official journal of the Movement Disorder Society.